MedPath

MeiraGTx LLC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
$315.6M
Website

Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia

Phase 2
Conditions
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
Interventions
Genetic: AAV2-hAQP1
First Posted Date
2024-08-09
Last Posted Date
2024-08-09
Lead Sponsor
MeiraGTx, LLC
Target Recruit Count
120
Registration Number
NCT06544798
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Atrium Health, Charlotte, North Carolina, United States

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Phase 2
Recruiting
Conditions
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
Interventions
Other: Placebo
Genetic: AAV2-hAQP1 Concentration 2
Genetic: AAV2-hAQP1 Concentration 1
First Posted Date
2023-07-03
Last Posted Date
2024-10-08
Lead Sponsor
MeiraGTx, LLC
Target Recruit Count
120
Registration Number
NCT05926765
Locations
๐Ÿ‡บ๐Ÿ‡ธ

City of Hope, Duarte, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Henry Ford Health, Detroit, Michigan, United States

๐Ÿ‡บ๐Ÿ‡ธ

UNC-Chapel Hill, Chapel Hill, North Carolina, United States

and more 19 locations

Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease

Phase 1
Conditions
Parkinson Disease
Interventions
Genetic: AAV-GAD
First Posted Date
2023-06-08
Last Posted Date
2024-08-06
Lead Sponsor
MeiraGTx, LLC
Target Recruit Count
14
Registration Number
NCT05894343
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Yale University, New Haven, Connecticut, United States

๐Ÿ‡บ๐Ÿ‡ธ

Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States

๐Ÿ‡บ๐Ÿ‡ธ

Weill Cornell Medicine, New York, New York, United States

and more 3 locations

A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants

Phase 1
Completed
Conditions
Parkinson Disease
Interventions
Genetic: AAV-GAD Dose 2
Genetic: AAV-GAD Dose 1
Procedure: Sham Surgery
First Posted Date
2022-11-02
Last Posted Date
2024-10-08
Lead Sponsor
MeiraGTx, LLC
Target Recruit Count
14
Registration Number
NCT05603312
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States

๐Ÿ‡บ๐Ÿ‡ธ

Weill Cornell Medicine, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Columbia University Irving Medical Center, New York, New York, United States

and more 3 locations

Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia

Active, not recruiting
Conditions
Radiation-induced Xerostomia
First Posted Date
2021-09-29
Last Posted Date
2024-04-17
Lead Sponsor
MeiraGTx, LLC
Target Recruit Count
22
Registration Number
NCT05060341
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Leland Stanford Junior University, Stanford, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Brigham and Women's Hospital, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

Atrium Health, Charlotte, North Carolina, United States

and more 1 locations

Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction

Phase 1
Active, not recruiting
Conditions
Radiation Induced Xerostomia
Salivary Hypofunction
Squamous Cell Head and Neck Cancer
Interventions
First Posted Date
2015-05-18
Last Posted Date
2023-08-18
Lead Sponsor
MeiraGTx, LLC
Target Recruit Count
17
Registration Number
NCT02446249
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath